Kai He

4.0k total citations · 1 hit paper
114 papers, 2.4k citations indexed

About

Kai He is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kai He has authored 114 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 39 papers in Molecular Biology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kai He's work include Cancer Immunotherapy and Biomarkers (33 papers), Lung Cancer Treatments and Mutations (21 papers) and Cancer Genomics and Diagnostics (17 papers). Kai He is often cited by papers focused on Cancer Immunotherapy and Biomarkers (33 papers), Lung Cancer Treatments and Mutations (21 papers) and Cancer Genomics and Diagnostics (17 papers). Kai He collaborates with scholars based in United States, China and Spain. Kai He's co-authors include David P. Carbone, Elias Aizenman, Stuart J. Frank, Dwight H. Owen, Gregory A. Otterson, Erin M. Bertino, Peter G. Shields, Marie-Anne Damiette Smit, Julie M. Bailis and Junran Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Kai He

108 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors

2024 62 citations Adam J. Schoenfeld, Sylvia M. Lee et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kai He United States	27	1.1k	999	502	436	335	114	2.4k
Soo Ok Lee United States	36	969 0.9×	1.2k 1.2×	510 1.0×	935 2.1×	692 2.1×	62	2.8k
Sonia Bergaya France	14	650 0.6×	627 0.6×	515 1.0×	308 0.7×	240 0.7×	15	1.9k
Carla Costa Portugal	15	843 0.7×	1.6k 1.6×	271 0.5×	203 0.5×	797 2.4×	29	2.8k
Stefania Stella Italy	26	464 0.4×	641 0.6×	614 1.2×	244 0.6×	220 0.7×	92	2.3k
Arno Schad Germany	32	835 0.7×	1.1k 1.1×	169 0.3×	289 0.7×	369 1.1×	94	2.6k
Philip Jonsson United States	27	773 0.7×	1.4k 1.4×	208 0.4×	462 1.1×	902 2.7×	41	2.8k
Xianxian Zheng United States	20	1.1k 1.0×	1.7k 1.7×	238 0.5×	958 2.2×	524 1.6×	30	3.4k
Maria Domenica Castellone Italy	34	1.2k 1.0×	2.0k 2.0×	487 1.0×	250 0.6×	532 1.6×	59	3.6k
Prashant Bavi Saudi Arabia	34	929 0.8×	1.4k 1.4×	215 0.4×	343 0.8×	699 2.1×	76	2.8k
Makoto Sumitomo Japan	28	849 0.7×	1.3k 1.3×	217 0.4×	794 1.8×	667 2.0×	133	2.5k

Countries citing papers authored by Kai He

Since Specialization

Citations

This map shows the geographic impact of Kai He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai He more than expected).

Fields of papers citing papers by Kai He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai He. The network helps show where Kai He may publish in the future.

Co-authorship network of co-authors of Kai He

This figure shows the co-authorship network connecting the top 25 collaborators of Kai He. A scholar is included among the top collaborators of Kai He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai He. Kai He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Miao, Kai He, Xue Dong, et al.. (2025). Human induced pluripotent stem cell-derived extracellular vesicles promote neuroprotection effects in rat optic nerve crush model. Experimental Eye Research. 258. 110505–110505.

Gao, Fengxia, Jianying Li, Jiacheng Jin, et al.. (2025). USP30 inhibition augments mitophagy to prevent T cell exhaustion. Science Advances. 11(33). eadv6902–eadv6902. 1 indexed citations

Chowdhury, Sayan Mullick, Feng Hong, Christian Rolfo, et al.. (2025). CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications. Biology. 14(2). 214–214.

He, Kai, Hyunwoo Kwon, Tomislav Čaval, et al.. (2024). Decoding the glycoproteome: a new frontier for biomarker discovery in cancer. Journal of Hematology & Oncology. 17(1). 12–12. 39 indexed citations

Wang, Yingcheng, et al.. (2024). Integrated management to achieve synergy in sugarcane production and quality in China. Field Crops Research. 317. 109552–109552. 3 indexed citations

Schoenfeld, Adam J., Sylvia M. Lee, Scott Gettinger, et al.. (2024). Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer Discovery. 14(8). 1389–1402. 62 indexed citations breakdown →

Jabbari, Ali, Wendy L. Frankel, Sujit Basu, et al.. (2024). IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10. The Journal of Immunology. 213(5). 559–566. 1 indexed citations

Tian, Zhong, Jiaxin Fang, Kai He, et al.. (2024). Associations of the magnesium depletion score and magnesium intake with diabetes among US adults: an analysis of the National Health and Nutrition Examination Survey 2011-2018. Epidemiology and Health. 46. e2024020–e2024020. 10 indexed citations

Dowlati, Afshin, Horst-Dieter Hummel, Stéphane Champiat, et al.. (2024). Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. Journal of Clinical Oncology. 42(29). 3392–3399. 22 indexed citations

10.

Borghaei, Hossein, Melissa L. Johnson, Edward B. Garon, et al.. (2023). LBA63 SAPPHIRE: Phase III study of sitravatinib plus nivolumab versus docetaxel in patients with previously treated advanced non-squamous non-small cell lung cancer (NSCLC). Annals of Oncology. 34. S1308–S1308. 4 indexed citations

11.

Zhao, Bao, Anjun Ma, Jianwen Chen, et al.. (2022). SUSD2 suppresses CD8+ T cell antitumor immunity by targeting IL-2 receptor signaling. Nature Immunology. 23(11). 1588–1599. 18 indexed citations

12.

He, Kai, et al.. (2022). Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p/IGF1R axis. Bioengineered. 13(2). 2004–2016. 16 indexed citations

13.

Darwiche, Kaid, Michał Seweryn, Vedat Yildiz, et al.. (2021). DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients. European Journal of Cancer. 147. 142–150. 24 indexed citations

14.

Li, Yanfei, Junwei Shen, Qian Zhu, et al.. (2021). Single-cell RNA sequencing of mouse left ventricle reveals cellular diversity and intercommunication. Physiological Genomics. 54(1). 11–21. 9 indexed citations

15.

Qiu, Zhaojun, Tao Liu, E. Ricky Chan, et al.. (2020). A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors. Cancer Research. 80(16). 3305–3318. 26 indexed citations

16.

Dong, Wenjuan, Xiaojin Wu, Shoubao Ma, et al.. (2019). The Mechanism of Anti–PD-L1 Antibody Efficacy against PD-L1–Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector. Cancer Discovery. 9(10). 1422–1437. 221 indexed citations

17.

Li, Mingjia, Daniel Spakowicz, Jarred Burkart, et al.. (2019). Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers. Journal of Cancer Research and Clinical Oncology. 145(10). 2541–2546. 82 indexed citations

18.

Spira, Alexander I., Collin M. Blakely, Kai He, et al.. (2018). Stage 2 enrollment complete: Sitravatinib in combination with nivolumab in NSCLC patients progressing on prior checkpoint inhibitor therapy. Annals of Oncology. 29. viii400–viii401. 9 indexed citations

19.

Miller, Eric D., James L. Fisher, Karl Haglund, et al.. (2018). Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database. Radiation Oncology. 13(1). 196–196. 17 indexed citations

20.

Shi, Xiaolin, et al.. (2015). Weak cation magnetic separation technology and MALDI-TOF-MS in screening serum protein markers in primary type I osteoporosis. Genetics and Molecular Research. 14(4). 15285–15294. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact